Immunoglobulin deposition diseases

Vinay Gupta, Wilson Gonsalves, Francis K. Buadi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Immunoglobulin deposition diseases are rare and unusual plasma cell dyscrasias. A tissue biopsy is required for diagnosis. Since the kidney is involved in most cases, a kidney biopsy usually provides the diagnosis. It is important to distinguish these disorders as their clinical presentation often mimics multiple myeloma and amyloidosis. The degree of renal involvement at presentation may vary from mild renal impairment to severe renal dysfunction requiring renal replacement therapy. The underlying lymphoproliferative or clonal plasma cell disorder usually has a low tumor burden compared to conditions such as multiple myeloma or Waldenstrom’s macroglobulinemia. The identification of the underlying hematological disorder guides therapeutic intervention. There has been significant improvement in the outcome of these patients, since the availability of novel agents such as immunomodulatory drugs, proteasome inhibitors, and with autologous stem cell transplantation. In this review, we address clinical presentation and outcomes with light-chain and heavy-chain monoclonal immunoglobulin deposition disease, Type I cryoglobulinemia, proliferative glomerulonephritis with monoclonal IgG deposits, C3 monoclonal-associated glomerulonephritis, immunotactoid glomerulonephropathy, Fanconi syndrome, and light-chain crystallopathy.

Original languageEnglish (US)
Title of host publicationBiology and Management of Unusual Plasma Cell Dyscrasias
PublisherSpringer New York
Pages109-125
Number of pages17
ISBN (Electronic)9781441968487
ISBN (Print)9781441968470
DOIs
StatePublished - Jan 1 2016

Fingerprint

Immunoglobulins
Kidney
Glomerulonephritis
Multiple Myeloma
Fanconi Syndrome
Biopsy
Light
Waldenstrom Macroglobulinemia
Cryoglobulinemia
Immunoglobulin Heavy Chains
Paraproteinemias
Proteasome Inhibitors
Renal Replacement Therapy
Stem Cell Transplantation
Amyloidosis
Rare Diseases
Plasma Cells
Tumor Burden
Immunoglobulin G
Pharmaceutical Preparations

Keywords

  • Immunoglobulin deposition disease
  • Light chain deposition disease
  • Proliferative glomerulonephritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gupta, V., Gonsalves, W., & Buadi, F. K. (2016). Immunoglobulin deposition diseases. In Biology and Management of Unusual Plasma Cell Dyscrasias (pp. 109-125). Springer New York. https://doi.org/10.1007/978-1-4419-6848-7_6

Immunoglobulin deposition diseases. / Gupta, Vinay; Gonsalves, Wilson; Buadi, Francis K.

Biology and Management of Unusual Plasma Cell Dyscrasias. Springer New York, 2016. p. 109-125.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gupta, V, Gonsalves, W & Buadi, FK 2016, Immunoglobulin deposition diseases. in Biology and Management of Unusual Plasma Cell Dyscrasias. Springer New York, pp. 109-125. https://doi.org/10.1007/978-1-4419-6848-7_6
Gupta V, Gonsalves W, Buadi FK. Immunoglobulin deposition diseases. In Biology and Management of Unusual Plasma Cell Dyscrasias. Springer New York. 2016. p. 109-125 https://doi.org/10.1007/978-1-4419-6848-7_6
Gupta, Vinay ; Gonsalves, Wilson ; Buadi, Francis K. / Immunoglobulin deposition diseases. Biology and Management of Unusual Plasma Cell Dyscrasias. Springer New York, 2016. pp. 109-125
@inbook{1bcc7d0414534fc18968c0d7d5bc5c88,
title = "Immunoglobulin deposition diseases",
abstract = "Immunoglobulin deposition diseases are rare and unusual plasma cell dyscrasias. A tissue biopsy is required for diagnosis. Since the kidney is involved in most cases, a kidney biopsy usually provides the diagnosis. It is important to distinguish these disorders as their clinical presentation often mimics multiple myeloma and amyloidosis. The degree of renal involvement at presentation may vary from mild renal impairment to severe renal dysfunction requiring renal replacement therapy. The underlying lymphoproliferative or clonal plasma cell disorder usually has a low tumor burden compared to conditions such as multiple myeloma or Waldenstrom’s macroglobulinemia. The identification of the underlying hematological disorder guides therapeutic intervention. There has been significant improvement in the outcome of these patients, since the availability of novel agents such as immunomodulatory drugs, proteasome inhibitors, and with autologous stem cell transplantation. In this review, we address clinical presentation and outcomes with light-chain and heavy-chain monoclonal immunoglobulin deposition disease, Type I cryoglobulinemia, proliferative glomerulonephritis with monoclonal IgG deposits, C3 monoclonal-associated glomerulonephritis, immunotactoid glomerulonephropathy, Fanconi syndrome, and light-chain crystallopathy.",
keywords = "Immunoglobulin deposition disease, Light chain deposition disease, Proliferative glomerulonephritis",
author = "Vinay Gupta and Wilson Gonsalves and Buadi, {Francis K.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-1-4419-6848-7_6",
language = "English (US)",
isbn = "9781441968470",
pages = "109--125",
booktitle = "Biology and Management of Unusual Plasma Cell Dyscrasias",
publisher = "Springer New York",

}

TY - CHAP

T1 - Immunoglobulin deposition diseases

AU - Gupta, Vinay

AU - Gonsalves, Wilson

AU - Buadi, Francis K.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Immunoglobulin deposition diseases are rare and unusual plasma cell dyscrasias. A tissue biopsy is required for diagnosis. Since the kidney is involved in most cases, a kidney biopsy usually provides the diagnosis. It is important to distinguish these disorders as their clinical presentation often mimics multiple myeloma and amyloidosis. The degree of renal involvement at presentation may vary from mild renal impairment to severe renal dysfunction requiring renal replacement therapy. The underlying lymphoproliferative or clonal plasma cell disorder usually has a low tumor burden compared to conditions such as multiple myeloma or Waldenstrom’s macroglobulinemia. The identification of the underlying hematological disorder guides therapeutic intervention. There has been significant improvement in the outcome of these patients, since the availability of novel agents such as immunomodulatory drugs, proteasome inhibitors, and with autologous stem cell transplantation. In this review, we address clinical presentation and outcomes with light-chain and heavy-chain monoclonal immunoglobulin deposition disease, Type I cryoglobulinemia, proliferative glomerulonephritis with monoclonal IgG deposits, C3 monoclonal-associated glomerulonephritis, immunotactoid glomerulonephropathy, Fanconi syndrome, and light-chain crystallopathy.

AB - Immunoglobulin deposition diseases are rare and unusual plasma cell dyscrasias. A tissue biopsy is required for diagnosis. Since the kidney is involved in most cases, a kidney biopsy usually provides the diagnosis. It is important to distinguish these disorders as their clinical presentation often mimics multiple myeloma and amyloidosis. The degree of renal involvement at presentation may vary from mild renal impairment to severe renal dysfunction requiring renal replacement therapy. The underlying lymphoproliferative or clonal plasma cell disorder usually has a low tumor burden compared to conditions such as multiple myeloma or Waldenstrom’s macroglobulinemia. The identification of the underlying hematological disorder guides therapeutic intervention. There has been significant improvement in the outcome of these patients, since the availability of novel agents such as immunomodulatory drugs, proteasome inhibitors, and with autologous stem cell transplantation. In this review, we address clinical presentation and outcomes with light-chain and heavy-chain monoclonal immunoglobulin deposition disease, Type I cryoglobulinemia, proliferative glomerulonephritis with monoclonal IgG deposits, C3 monoclonal-associated glomerulonephritis, immunotactoid glomerulonephropathy, Fanconi syndrome, and light-chain crystallopathy.

KW - Immunoglobulin deposition disease

KW - Light chain deposition disease

KW - Proliferative glomerulonephritis

UR - http://www.scopus.com/inward/record.url?scp=85006427673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006427673&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-6848-7_6

DO - 10.1007/978-1-4419-6848-7_6

M3 - Chapter

AN - SCOPUS:85006427673

SN - 9781441968470

SP - 109

EP - 125

BT - Biology and Management of Unusual Plasma Cell Dyscrasias

PB - Springer New York

ER -